In tauopathy-associated neurodegenerative diseases, the DNA aptamer BW1c, administered by retro-orbital injection, has demonstrated the ability to cross the BBB and to bind with high affinity (Kd = 6.6 nM) to monomeric Tau protein. Here, MAPT is linked to neurodegenerative disease.